# Cancer Prevention Pharmaceuticals, Inc. — Form D

Cancer Prevention Pharmaceuticals, Inc. of TUCSON, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2012-11-19. The offering totals $5.0M, of which $355K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2012-11-19
- Form: D
- Accession: 0001471002-12-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $5.0M
- Amount sold: $355K
- Remaining: $4.6M
- Minimum investment: $20K
- Investors: 2
- Date of first sale: 2012-10-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-187203

## Issuer

- Name: Cancer Prevention Pharmaceuticals, Inc.
- CIK: 0001471002
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 1760 EAST RIVER ROAD, SUITE 250, TUCSON, AZ, 85718
- Phone: 520-908-7774

## Officers, directors & promoters (17)

| Name | Role | Location |
| --- | --- | --- |
| Jon Saxe | Director | Mountain View, CA |
| Jeffrey Jacob | Director | New York, NY |
| Jeffrey Jacob | Executive Officer | New York, NY |
| Richard Love | Director | Scottsdale, AZ |
| John Saxe | Director | TUCSON, AZ |
| Eugene Gerner, Ph.D. | Director | TUCSON, AZ |
| Daniel Donovan | Director | TUCSON, AZ |
| Andrew Levitch | Executive Officer | SAN DIEGO, CA |
| Christopher Richied | Executive Officer | Tucson, AZ |
| Eugene W Gerner | Director | Tucson, AZ |
| Eugene W Gerner | Executive Officer | Tucson, AZ |
| Daniel W Donovan | Director | Tucson, AZ |
| Frank W Meyskens | Director | Irvine, CA |
| Richard W Love | Director | Scottsdale, AZ |
| Jeffrey E Jacob | Director | Tucson, AZ |
| Jeffrey E Jacob | Executive Officer | Tucson, AZ |
| Frank Meyskens | Director | Irine, CA |

## Other filings by this issuer (8)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-01-29](https://search.stillhousedata.com/formd/0001213900-21-005247) | D | $3.0M | $400K |
| [2017-09-14](https://search.stillhousedata.com/formd/0001144204-17-047981) | D | $5.0M | $5.0M |
| [2017-04-25](https://search.stillhousedata.com/formd/0001144204-17-022032) | D | $3.0M | $700K |
| [2016-01-22](https://search.stillhousedata.com/formd/0001144204-16-076643) | D | $5.0M | $5.0M |
| [2016-01-14](https://search.stillhousedata.com/formd/0001144204-16-075593) | D | $3.0M | $835K |
| [2013-10-31](https://search.stillhousedata.com/formd/0001471002-13-000001) | D/A | $6.0M | $4.3M |
| [2011-03-24](https://search.stillhousedata.com/formd/0001471002-11-000003) | D | $2.0M | $550K |
| [2009-09-01](https://search.stillhousedata.com/formd/0001471002-09-000001) | D | $2.0M | $1.3M |

## More

- [CIK 1471002 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1471002&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001471002-12-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.